author-photo

Richard D. Carvajal

Columbia University Medical Center
Memorial Sloan Kettering Cancer Center
Columbia University

313

Papers

20498

Citations

Citation Trend

Filter By

Papers (313) Sort By

Journal Conference Others

LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.

2021 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (4)
Initial findings of the first-in-human phase I study of AGEN2373, a conditionally active CD137 agonist antibody, in patients (pts) with advanced solid tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
OncoTree: A Cancer Classification System for Precision Oncology.

2021
Show All
- Source
- Cite
- Save
Citations (7)
Abstract CT038: Kinetics of radiographic response for tebentafusp (tebe) in previously treated metastatic uveal melanoma (mUM) patients (pts) achieving prolonged survival

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Abstract CT218: Phase 1/2 study of a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), BDC-1001, alone and in combination with pembrolizumab (pembro) in patients (pts) with HER2-expressing advanced solid tumors

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell Carcinoma.

2021 Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT-03-02: Phase 1/2 study of a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), BDC-1001, as a single agent and in combination with an immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Large expert-curated database for benchmarking document similarity detection in biomedical literature search

2021 Elements
Show All
- Source
- Cite
- Save
Citations (0)